Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

1 registered trial, newest registry update first. Showing only trials linked to Cagri-Sema.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
NCT03600480
Cagri-Sema, CagrilintidePhase 1CompletedNovo Nordisk A/S96Jun 12, 2020Nov 17, 2021

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.